Carlsmed, Inc. (CARL)Healthcare | Health Information Services | Carlsbad, United States | NasdaqGS
16.88 USD
+0.13
(0.776%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 16.65 -0.23 (-0.230%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:15 a.m. EDT
The immediate catalyst is a powerful technical breakout driven by a massive 38% surge over the last two weeks, pushing the price from $13.43 to $16.05. This momentum is reinforced by a 'strong buy' consensus from analysts, a recent $1.81 million institutional investment, and a specific 'Buy' rating from Goldman Sachs, suggesting significant near-term upside potential despite the lack of historical price data. However, the long-term outlook remains neutral due to the absence of a multi-year price trajectory to validate business quality; without several years of performance history, it is impossible to confirm if the current rally reflects a durable competitive advantage or merely a speculative premium. Fundamentally, the company is unprofitable with negative operating margins and free cash flow, which prevents a high long-term rating regardless of the recent price action. Finally, there is no dividend history, offering zero income yield. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.062232 |
| MSTL | 0.065429 |
| AutoTheta | 0.073223 |
| AutoARIMA | 0.131431 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 2.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.796 |
| Excess Kurtosis | -0.45 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 26.015 |
| Revenue per Share | 2.482 |
| Market Cap | 460,870,304 |
| Forward P/E | -12.23 |
| Profit Margins | -57.42% |
| Website | https://carlsmed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.24759793 |
| Address1 | 1,800 Aston Avenue |
| Address2 | Suite 100 |
| All Time High | 17.23 |
| All Time Low | 8.5 |
| Ask | 21.41 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 197,340 |
| Average Daily Volume3 Month | 148,776 |
| Average Volume | 148,776 |
| Average Volume10Days | 197,340 |
| Bid | 12.06 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 3.094 |
| City | Carlsbad |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 16.88 |
| Current Ratio | 8.841 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 16.99 |
| Day Low | 16.52 |
| Debt To Equity | 26.015 |
| Display Name | Carlsmed |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -38,256,000 |
| Ebitda Margins | -0.60441 |
| Enterprise To Ebitda | -10.288 |
| Enterprise To Revenue | 6.218 |
| Enterprise Value | 393,563,296 |
| Eps Current Year | -1.41 |
| Eps Forward | -1.38 |
| Eps Trailing Twelve Months | -2.35 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 12.8114 |
| Fifty Day Average Change | 4.0685987 |
| Fifty Day Average Change Percent | 0.31757644 |
| Fifty Two Week Change Percent | 24.759792 |
| Fifty Two Week High | 17.23 |
| Fifty Two Week High Change | -0.35000038 |
| Fifty Two Week High Change Percent | -0.020313429 |
| Fifty Two Week Low | 8.5 |
| Fifty Two Week Low Change | 8.379999 |
| Fifty Two Week Low Change Percent | 0.9858823 |
| Fifty Two Week Range | 8.5 - 17.23 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,753,277,400,000 |
| Float Shares | 15,669,044 |
| Forward Eps | -1.38 |
| Forward P E | -12.231883 |
| Free Cashflow | -26,408,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 127 |
| Fullday Change | 0.129999 |
| Fullday Change Percent | 0.776114 |
| Fullday Price | 16.65 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.76628 |
| Gross Profits | 48,502,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.44422 |
| Held Percent Institutions | 0.40297002 |
| Implied Shares Outstanding | 27,302,743 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Ipo Expected Date | 2,025-07-23 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. |
| Long Name | Carlsmed, Inc. |
| Market | us_market |
| Market Cap | 460,870,304 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_629940925 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -36,345,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 458,413,054 |
| Number Of Analyst Opinions | 5 |
| Open | 16.86 |
| Operating Cashflow | -34,145,000 |
| Operating Margins | -0.58268 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 760 766 1923 |
| Post Market Change | -0.22999954 |
| Post Market Change Percent | -1.3625566 |
| Post Market Price | 16.65 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 16.75 |
| Price Eps Current Year | -11.971631 |
| Price Hint | 2 |
| Price To Book | 5.4557204 |
| Price To Sales Trailing12 Months | 7.2813067 |
| Profit Margins | -0.57422 |
| Quick Ratio | 8.308 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.4 |
| Region | US |
| Regular Market Change | 0.129999 |
| Regular Market Change Percent | 0.776114 |
| Regular Market Day High | 16.99 |
| Regular Market Day Low | 16.52 |
| Regular Market Day Range | 16.52 - 16.99 |
| Regular Market Open | 16.86 |
| Regular Market Previous Close | 16.75 |
| Regular Market Price | 16.88 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 121,246 |
| Return On Assets | -0.28186 |
| Return On Equity | -0.66141 |
| Revenue Growth | 0.567 |
| Revenue Per Share | 2.482 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 27,302,743 |
| Shares Percent Shares Out | 0.0482 |
| Shares Short | 1,316,035 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,357,636 |
| Short Name | Carlsmed, Inc. |
| Short Percent Of Float | 0.1287 |
| Short Ratio | 9.46 |
| Source Interval | 15 |
| State | CA |
| Symbol | CARL |
| Target High Price | 23.0 |
| Target Low Price | 17.0 |
| Target Mean Price | 19.2 |
| Target Median Price | 18.0 |
| Total Cash | 89,224,000 |
| Total Cash Per Share | 3.268 |
| Total Debt | 21,917,000 |
| Total Revenue | 63,295,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.35 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.052575 |
| Two Hundred Day Average Change | 4.827424 |
| Two Hundred Day Average Change Percent | 0.40053052 |
| Type Disp | Equity |
| Volume | 121,246 |
| Website | https://carlsmed.com |
| Zip | 92,008 |